Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hereditary Angioedema Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hereditary Angioedema Drugmarket, defines the market attractiveness level of Hereditary Angioedema Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hereditary Angioedema Drug industry, describes the types of Hereditary Angioedema Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hereditary Angioedema Drug market and the development prospects and opportunities of Hereditary Angioedema Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hereditary Angioedema Drug market in Chapter 13.
By Player:
CSL Limited
Shire plc
IBio Inc
Ionis Pharmaceuticals, Inc
Pharming Group NV
BioCryst Pharmaceuticals, Inc
By Type:
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By End-User:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hereditary Angioedema Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hereditary Angioedema Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hereditary Angioedema Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hereditary Angioedema Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hereditary Angioedema Drug Market Analysis and Outlook to 2022
-
7.1 Global Hereditary Angioedema Drug Consumption (2017-2022)
-
7.2 United States Hereditary Angioedema Drug Consumption (2017-2022)
-
7.3 Europe Hereditary Angioedema Drug Consumption (2017-2022)
-
7.4 China Hereditary Angioedema Drug Consumption (2017-2022)
-
7.5 Japan Hereditary Angioedema Drug Consumption (2017-2022)
-
7.6 India Hereditary Angioedema Drug Consumption (2017-2022)
-
7.7 South Korea Hereditary Angioedema Drug Consumption (2017-2022)
8 Region and Country-wise Hereditary Angioedema Drug Market Analysis and Outlook to 2028
-
8.1 Global Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.2 United States Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.3 Europe Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.4 China Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.5 Japan Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.6 India Hereditary Angioedema Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Hereditary Angioedema Drug Consumption Forecast (2022-2028)
9 Global Hereditary Angioedema Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Hereditary Angioedema Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kallikrein Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Selective Bradykinin B2 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.2 Global Hereditary Angioedema Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Hereditary Angioedema Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Hereditary Angioedema Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Kallikrein Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Selective Bradykinin B2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hereditary Angioedema Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Hereditary Angioedema Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hereditary Angioedema Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hereditary Angioedema Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hereditary Angioedema Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hereditary Angioedema Drug Market Competitive Analysis
-
14.1 CSL Limited
-
14.1.1 CSL Limited Company Details
-
14.1.2 CSL Limited Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CSL Limited Hereditary Angioedema Drug Product and Service
-
14.2 Shire plc
-
14.2.1 Shire plc Company Details
-
14.2.2 Shire plc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire plc Hereditary Angioedema Drug Product and Service
-
14.3 IBio Inc
-
14.3.1 IBio Inc Company Details
-
14.3.2 IBio Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 IBio Inc Hereditary Angioedema Drug Product and Service
-
14.4 Ionis Pharmaceuticals, Inc
-
14.4.1 Ionis Pharmaceuticals, Inc Company Details
-
14.4.2 Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Product and Service
-
14.5 Pharming Group NV
-
14.5.1 Pharming Group NV Company Details
-
14.5.2 Pharming Group NV Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pharming Group NV Hereditary Angioedema Drug Product and Service
-
14.6 BioCryst Pharmaceuticals, Inc
-
14.6.1 BioCryst Pharmaceuticals, Inc Company Details
-
14.6.2 BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hereditary Angioedema Drug
-
Figure Hereditary Angioedema Drug Picture
-
Table Global Hereditary Angioedema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hereditary Angioedema Drug Consumption by Country (2017-2022)
-
Figure United States Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Figure China Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Figure India Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hereditary Angioedema Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Hereditary Angioedema Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hereditary Angioedema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global C1 Esterase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Kallikrein Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Bradykinin B2 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global C1 Esterase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kallikrein Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Bradykinin B2 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hereditary Angioedema Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hereditary Angioedema Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Hereditary Angioedema Drug Product and Service
-
Table Shire plc (Foundation Year, Company Profile and etc.)
-
Table Shire plc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire plc Hereditary Angioedema Drug Product and Service
-
Table IBio Inc (Foundation Year, Company Profile and etc.)
-
Table IBio Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBio Inc Hereditary Angioedema Drug Product and Service
-
Table Ionis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Product and Service
-
Table Pharming Group NV (Foundation Year, Company Profile and etc.)
-
Table Pharming Group NV Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group NV Hereditary Angioedema Drug Product and Service
-
Table BioCryst Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Product and Service
-
